Matches in Wikidata for { <http://www.wikidata.org/entity/Q90046702> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q90046702 description "article scientifique publié en 2019" @default.
- Q90046702 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q90046702 description "scientific article published on 01 April 2019" @default.
- Q90046702 description "wetenschappelijk artikel" @default.
- Q90046702 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q90046702 name "Previous exposure to bevacizumab indicated inferior benefits from PD-1/PD-L1 inhibitors in nonsquamous NSCLC" @default.
- Q90046702 name "Previous exposure to bevacizumab indicated inferior benefits from PD-1/PD-L1 inhibitors in nonsquamous NSCLC" @default.
- Q90046702 type Item @default.
- Q90046702 label "Previous exposure to bevacizumab indicated inferior benefits from PD-1/PD-L1 inhibitors in nonsquamous NSCLC" @default.
- Q90046702 label "Previous exposure to bevacizumab indicated inferior benefits from PD-1/PD-L1 inhibitors in nonsquamous NSCLC" @default.
- Q90046702 prefLabel "Previous exposure to bevacizumab indicated inferior benefits from PD-1/PD-L1 inhibitors in nonsquamous NSCLC" @default.
- Q90046702 prefLabel "Previous exposure to bevacizumab indicated inferior benefits from PD-1/PD-L1 inhibitors in nonsquamous NSCLC" @default.
- Q90046702 P1433 Q90046702-A066A1C1-553A-4932-AE1B-148932C4A343 @default.
- Q90046702 P1476 Q90046702-4941E253-F44C-4640-AB94-006FEDB22B44 @default.
- Q90046702 P2093 Q90046702-2F9B14B2-70D7-4F0E-9317-71BE88AAFF2D @default.
- Q90046702 P2093 Q90046702-41D765C4-C254-42C6-B579-295B0D6C3A37 @default.
- Q90046702 P2093 Q90046702-72394900-905D-4300-95EA-AD894D167E9F @default.
- Q90046702 P304 Q90046702-9C99A01C-FFFC-46E8-9325-4B8DE6420DEE @default.
- Q90046702 P31 Q90046702-52913AAA-463C-4B37-BE10-49FFB6AD1117 @default.
- Q90046702 P356 Q90046702-0A0AB4DA-2DE1-4B59-B274-686E1EB4204A @default.
- Q90046702 P478 Q90046702-CEC0435F-14C0-4A1B-9BA8-1A0A5B363D32 @default.
- Q90046702 P577 Q90046702-6ADFD32E-9E57-4E91-9DCC-81BE1881FAD7 @default.
- Q90046702 P921 Q90046702-3E8817DE-9BF6-4580-9D0E-4E894D513122 @default.
- Q90046702 P921 Q90046702-78417289-5D63-44E7-BD51-7089D35A6BA5 @default.
- Q90046702 P356 MDZ063.069 @default.
- Q90046702 P1433 Q326122 @default.
- Q90046702 P1476 "Previous exposure to bevacizumab indicated inferior benefits from PD-1/PD-L1 inhibitors in nonsquamous NSCLC" @default.
- Q90046702 P2093 "C Zhou" @default.
- Q90046702 P2093 "F Zhou" @default.
- Q90046702 P2093 "Y Pan" @default.
- Q90046702 P304 "ii62" @default.
- Q90046702 P31 Q13442814 @default.
- Q90046702 P356 "10.1093/ANNONC/MDZ063.069" @default.
- Q90046702 P478 "30 Suppl 2" @default.
- Q90046702 P577 "2019-04-01T00:00:00Z" @default.
- Q90046702 P921 Q3658562 @default.
- Q90046702 P921 Q413299 @default.